David is one of the Partners of our Corporate team in Barcelona. He specializes in corporate transactions, private equity, venture capital and financing, in most cases, with an international component. He is ranked by Chambers Europe and Best Lawyers as a leading lawyer in Spain.
He usually acts for foreign corporations and investors operating in Spain and has wide experience in international M&A, where he usually works along with other offices of Osborne Clarke International and US law firms. He also acts for US and European venture capital funds investing in Spanish startups, mainly in the technology and healthcare industries. He is closely connected with the Barcelona entrepreneurial and venture capital community and is a lecturer at several publicly and privately funded programs for local startups across the IT, cleantech and healthtech sectors.
David is fluent in English and Spanish and was educated at the University of Navarra, graduating with a law degree in 1996, then as LLM in 1998 from IE Business School. David is a member of the Barcelona Bar Association, International Bar Association and American Bar Association. He is also a member of the Spanish Private Equity and Venture Capital Institute (Instituto de Capital Riesgo), Barcelona Tech City (private association engaged in the promotion of Barcelona as a technology and digital cluster in the South of Europe) and the Professional Council of ESADE’s Law School.
Advised on US$4bn leveraged acquisition of Talecris Biotherapeutics.
Advised on US$1.5 leveraged acquisition of Novartis diagnostic division
Advised CoStar Group on acquisition of the business of Belbex Corporate in Spain.
Eight Road Ventures
Advised Eight Road Ventures on US$12.6m finance round in Packlink
Ysios, Johnson & Johnson – JJDC and Caixa Capital Risc
Advised lead investors on €11m finance round in Aelix Therapeutics
Advised Kennet Partners on €10.5m finance round in ABA English
Highland Capital Partners
Advised Highland on US$30m investment round in Social Point
Considerations on the suspension of the liberalization regime of foreign direct investments in Spain
As a consequence of the crisis triggered by Covid-19, on March 2020 the Spanish Government decided to adopt certain measures...
Article 348bis of the Spanish Companies Law has generated an intense doctrinal and jurisprudential debate over recent years, especially after...
The business judgement rule as a mechanism to protect directors from liability when making business decisions
Directors are elected by the shareholders of a company to manage the company by exercising their decision-making role. All business...
The appointment and removal of directors without being included in the agenda of the general shareholders meeting
The Companies Act sets out certain cases in which the board may appoint or remove directors, even if such decision...